Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow.

Affinity-purified rabbit antibody to human lambda and kappa chains (R alpha H lambda kappa) was conjugated to the A-chain of the plant toxin, ricin. The resulting immunotoxin (R alpha H lambda kappa-A) killed cells from the tumor cell line Daudi, which bears surface immunoglobulin, but was nontoxic to the CFU-E, BFU-E, and CFU-GM of human bone marrow. R alpha H lambda kappa-A eliminated 99% of clonogenic Daudi cells that had been mixed with marrow cells in vitro, without demonstrable toxicity to hematopoietic cells. Thus, in vitro treatment of marrow with R alpha H lambda kappa-A may increase the incidence of cure following autologous bone marrow transplantation for the treatment of human B-cell malignancies.

[1]  J. Kearney,et al.  Studies on the clonal origin of human B cell leukemia using monoclonal anti-idiotype antibodies. , 1982, Journal of immunology.

[2]  A. Fauci,et al.  Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates , 1982, The Journal of experimental medicine.

[3]  R. Bast,et al.  AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT , 1982, The Lancet.

[4]  D. Mason,et al.  Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugate , 1982, Nature.

[5]  J. Uhr,et al.  In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins , 1982, The Journal of experimental medicine.

[6]  J. Guillot,et al.  Purification and lectins from Ricinus communis by combination of affinity and ion-exchange chromatography and characterization of the isolated proteins. , 1982, Journal of immunological methods.

[7]  D. Neville,et al.  Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin , 1982, Journal of Experimental Medicine.

[8]  J. Uhr,et al.  Selective killing of leukaemia cells by antibody–toxin conjugates: implications for autologous bone marrow transplantation , 1982, Nature.

[9]  Dominique,et al.  Immunotoxins: Hybrid Molecules Combining High Specificity and Potent Cytotoxicity , 1982, Immunological reviews.

[10]  J. Uhr,et al.  Neoplastic B Cells as Targets for Antibody‐Ricin A Chain Immunotoxins , 1982, Immunological reviews.

[11]  J. Ritz,et al.  Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. , 1982, Cancer research.

[12]  I. Trowbridge,et al.  Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cells , 1981, Nature.

[13]  V. Raso,et al.  Hybrid antibodies with dual specificity for the delivery of ricin to immunoglobulin-bearing target cells. , 1981, Cancer Research.

[14]  P. Isakson,et al.  Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Schlunk,et al.  The influence of culture conditions on the production of colony-stimulating activity by human placenta. , 1980, Experimental Hematology.

[16]  S. Strober,et al.  Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS. , 1979, Journal of immunology.

[17]  D. Cawley,et al.  Homology between ricin and Ricinus communis agglutinin: amino terminal sequence analysis and protein synthesis inhibition studies. , 1978, Archives of biochemistry and biophysics.

[18]  J. Uhr,et al.  Cell surface immunoglobulin. XXII. Reappearance of surface IgM and IgD on murine splenocytes after removal by capping. , 1977, Journal of Immunology.

[19]  R. Zittoun,et al.  Normal Human Bone Marrow Cultures in Vitro: Cellular Composition and Maturation of the Granulocytic Colonies , 1977, British Journal of Haematology.

[20]  T. Moehring,et al.  Selection and characterization of cells resistant to diphtheria toxin and pseudomonas exotoxin A: presumptive translational mutants , 1977, Cell.

[21]  H. Pelham,et al.  An efficient mRNA-dependent translation system from reticulocyte lysates. , 1976, European journal of biochemistry.

[22]  E. Vitetta,et al.  Cell surface immunoglobulin. XVIII. Functional differences of B lymphocytes bearing different surface immunoglobulin isotypes , 1976, The Journal of experimental medicine.

[23]  A. Axelrad,et al.  Improved plasma culture system for production of erythrocytic colonies in vitro: quantitative assay method for CFU-E. , 1974, Blood.

[24]  E. Klein,et al.  Isolation of 7S IgM and kappa chains from the surface membrane of tissue culture cells derived from a Burkitt lymphoma. , 1971, Journal of immunology.

[25]  L. Sachs,et al.  The continued requirement for inducer for the development of macrophage and granulocyte colonies , 1968, Journal of cellular physiology.

[26]  George,et al.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. , 1968, Cancer research.